Viewing nowJW Minoxidil Tablet (Minoxidil)
Minoxidil 5mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

MFDS item code 202600392 · Approved 2026.02.11
Treatment of symptomatic hypertension, hypertension with target-organ damage, and resistant hypertension
This medication is used in the treatment of hypertension caused by symptomatic or target organ damage, as well as resistant hypertension that does not respond even to the addition of diuretics and two types of antihypertensive agents.
1. Adults (12 years and older): The initial dose of minoxidil is 5mg orally once daily, and the maintenance dose is 10-40mg per day in 1 to several divided doses. Up to 100mg per day may be administered. 3. Frequency of administration: During treatment with this drug, the magnitude of daily fluctuations in arterial blood pressure is proportional to the amount of blood pressure reduction. If the reduction in supine diastolic blood pressure is less than 30mmHg, the drug may be administered once daily; if the reduction is 30mmHg or greater, administer it in 2 divided doses per day. 4. Dose changes: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days as a general rule, since an adequate response to a dose may take 3 days or longer to develop. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. 5. Concomitant administration 1) Diuretics: This drug should be administered concomitantly with a diuretic in patients who depend on renal function to maintain salt and water balance. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50mg per dose, 2 times daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose, once daily) ③ Furosemide (40mg per dose, 2 times daily) If excessive salt and water retention results in a weight gain of approximately 1.8kg or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. 2) β-blockers or other sympatholytic agents: During treatment with this drug, administer a β-blocker in divided doses equivalent to 80-160mg of propranolol per day. If β-blockers are contraindicated, methyldopa (250-750mg per dose, 2 times daily) may be administered instead. Since methyldopa takes time to exert its effects, administer it at least 24 hours before starting this drug. Sympatholytic agents may not completely block the increase in heart rate caused by this drug, although they can generally prevent tachycardia. Patients receiving a β-blocker before starting therapy with this drug typically have bradycardia, or their heart rate is expected to increase to normal when this drug is administered. When this drug is administered concomitantly with a β-blocker or another sympatholytic agent, their opposing effects on the heart offset each other, resulting in little change in heart rate. Adjust the dose as appropriate according to age and symptoms.
Children (12 years and younger): The initial dose is 0.2mg/kg once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25mg-1.0mg/kg per day. Up to 50mg per day may be administered.
This drug should not be used in patients with certain diseases. For example, it should not be administered to patients with rare tumors known as pheochromocytoma, as it may increase the secretion of substances from the tumor. Moreover, patients with pulmonary hypertension due to mitral stenosis, acute myocardial infarction patients, and those who have experienced allergic reactions to this drug are also excluded from treatment. Patients with chronic congestive heart failure, severe renal failure, and angina should use this drug with greater caution. These patients may experience worsening conditions, and treatment should be conducted under strict medical supervision. Common side effects may include abnormal hair growth when taking this medication. Hair growth may increase particularly between the eyebrows, on the face, arms, and legs, and this phenomenon typically begins 3 to 6 weeks after starting the medication. Stopping the medication will halt new hair growth, but it may take several months to return to the original state. This side effect is not related to hormonal abnormalities, but caution is advised, especially for children and women. Additionally, hypersensitivity reactions such as skin rashes or blisters, and in severe cases, conditions like Stevens-Johnson syndrome, may occur. Laboratory tests may show decreased platelet or white blood cell counts, and liver function test levels may temporarily rise. Changes in heart electrical signals may be observed on electrocardiograms, but most will recover naturally with continued treatment. Serious problems with heart function are rare. Rarely, pericardial effusion may occur, especially in patients with poor kidney function, and this is more likely to be observed. In such cases, it is necessary to check the condition via ultrasound and adjust treatment if necessary. Other symptoms such as weight gain, peripheral edema, increased heart rate, digestive disturbances, rash, breast pain, gynecomastia, anemia, headache, intermittent claudication, frequent menstruation, nausea and vomiting, decreased platelet counts, decreased white blood cells, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, electrocardiogram abnormalities, pericardial effusion, angina, and palpitations may also occur. This medication is usually used in conjunction with diuretics to prevent the accumulation of body water and salt. Body weight and fluid status should be checked frequently, and if abnormalities occur, adjustments to diuretic dosages or restrictions on salt intake may be necessary. Due to its vasodilating effects, this medication may speed up the heart rate, which may lead to chest pain, so it is often taken with heart medications to prevent this. Patients with poor kidney function or those undergoing dialysis should have their dosages reduced, and appropriate measures should be taken to prevent further kidney function deterioration. Myocardial infarction patients should only use this medication after their condition has stabilized. While on this medication, regular examinations such as urinalysis, kidney function tests, electrocardiograms, chest X-rays, and echocardiograms are necessary. There may be interactions with other medications, so it is important to consult with a physician when taking antihypertensives, antidepressants, steroids, or non-steroidal anti-inflammatory drugs. Pregnant women should avoid taking this drug as its safety has not been established, and nursing mothers should also avoid administration or stop breastfeeding if possible. There is limited experience using this medication in children, particularly in newborns, so administration should be done with caution. In the event of an overdose, intravenous saline may be administered to maintain blood pressure and promote urination, while cardiac stimulants should be avoided as they may increase cardiac burden. In critical cases, professional medical treatment may be necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should ideally be maintained between 1 to 30 degrees Celsius.
White or almost white round tablets
30 tablets/bottle, 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMinoxidil 5mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Minoxidil 5mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 3g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hanmi Pharmaceutical Co., Ltd.
Minoxidil 5g
Solution · OTC medication
JW Pharmaceutical Corp.
Minoxidil 3g
Solution · OTC medication
Haitai HTB Co., Ltd.
Minoxidil 5g
Solution · OTC medication
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.